Zoetis (ZTS) Net Cash Flow (2012 - 2026)
Zoetis (ZTS) posted quarterly Net Cash Flow of -$526.0 million for Q1 2026, down 44.11% year-over-year from -$941.1 million in Q1 2025, and down 326.72% quarter-over-quarter from $232.0 million in Q4 2025.
Zoetis (ZTS) Net Cash Flow (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Net Cash Flow for 15 consecutive years, with -$526.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow fell 44.11% year-over-year to -$526.0 million; the TTM figure through Mar 2026 stood at $125.0 million (up 138.23% YoY), while the FY2025 annual figure was $286.0 million, up 1400.0% from the prior year.
- Net Cash Flow declined to -$526.0 million in Q1 2026 per ZTS's latest filing, from $232.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $1.1 billion in Q4 2022 and bottomed at -$1.5 billion in Q1 2023.
- Historically, Net Cash Flow has averaged -$98.2 million across 5 years, with a median of -$127.0 million in 2022.
- On a YoY basis, Net Cash Flow climbed as much as 385.65% in 2022 and fell as far as 17600.0% in 2022.
- Zoetis' Net Cash Flow stood at $1.1 billion in 2022, then tumbled by 73.22% to $290.0 million in 2023, then slipped by 1.38% to $286.0 million in 2024, then dropped by 18.88% to $232.0 million in 2025, then slumped by 326.72% to -$526.0 million in 2026.
- Business Quant data shows ZTS's Net Cash Flow at -$526.0 million in Q1 2026, $232.0 million in Q4 2025, and $644.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 159.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -458.00 Mn |
| Jun 30, 2026 | -458.00 Mn |
| Mar 31, 2026 | -526.00 Mn |
| Mar 31, 2026 | -526.00 Mn |
| Dec 31, 2025 | 232.00 Mn |
| Dec 31, 2025 | 232.00 Mn |
| Sep 30, 2025 | 644.00 Mn |
| Sep 30, 2025 | 644.00 Mn |
| Jun 30, 2025 | -225.00 Mn |
| Jun 30, 2025 | -225.00 Mn |
| Mar 31, 2025 | -365.00 Mn |
| Mar 31, 2025 | -365.00 Mn |
| Dec 31, 2024 | 286.00 Mn |
| Dec 31, 2024 | 286.00 Mn |
| Sep 30, 2024 | 145.00 Mn |
| Sep 30, 2024 | 145.00 Mn |
| Jun 30, 2024 | -393.00 Mn |
| Jun 30, 2024 | -393.00 Mn |
| Mar 31, 2024 | -60.00 Mn |
| Mar 31, 2024 | -60.00 Mn |